Skip to content

Denmark presents its official bid to host EMA in Copenhagen

31.07.2017  15:00

Today, the Government of Denmark has made public its official bid to host the European Medicines Agency (EMA) titled Copenhagen offers the optimal conditions aiming at providing a plug and play solution to the relocation of EMA.

Denmark is committed to ensuring an optimal setting for the activities of the European Medicines Agency so all medicines available on the EU market are safe, effective and of high quality. The main elements of the Danish bid includes:

  • Copenhagen stands ready with a transition plan, which will ensure business continuity during the relocation of EMA.
  • A new, modern and sustainable building with a superb location less than 10 minutes from the airport and 20 years of rent – free of charge.
  • High quality of life and dedicated relocation services for employees and their families.
  • Copenhagen offers support to IT transition in the last critical phase, support and counselling to EMA staff and families, and targeted talent attraction.
  • A strong life sciences cluster – across science, education and regulatory affairs – provides an ideal ecosystem for innovation and good recruitment opportunities.

The Minister for Foreign Affairs Anders Samuelsen: “London has been a great home for EMA for years. We now have to find a new location that can provide an equally good environment for the Agency to continue its work to the benefit of European health. We believe Copenhagen can offer just that – a plug and play solution. The business continuity of the Agency is at the core of our bid. We come prepared with a detailed transition plan taking into account all relevant details of the potential relocation to Copenhagen. By reserving an existing, newly build building – Copenhagen Towers – we offer a credible and sustainable solution for EMA. There is no doubt that EMA can be fully operational in Copenhagen by March 2019.”

The Minister for Health Ellen Trane Nørby: “Denmark has a strong tradition for safeguarding patient safety, a world class research environment, a pharmaceutical industry among the leading globally and we would be more than ready to take on the responsibility for EMA's continuous pursuit of public health work. We believe that a relocation to Copenhagen will ensure not only a smooth transition, but also a strong and long term solution for the future of the agency to the benefit of all European patients."

On 8 February 2017, the Danish Government announced that it would put forward a candidature for the relocation of the European Medicines Agency (EMA). Following the decision of the Heads of State and Government in the margins of the European Council (art. 50) on June 22 – 23 regarding the procedure and criteria for the relocation of EMA and the European Banking Authority (EBA), the Danish Government has now put forward its official candidature including detailed responses to the individual criteria.

For more information, including the official candidature and a video presentation of the Danish candidature, visit or follow the Special Envoy of the Danish candidature Lars Rebien Sørensen on Twitter.